Company / Depreciation & Amortization
Beam Therapeutics Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$22.3M
FY2025
5-year range
$7.5M / $22.3M
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#43 of 168
Health Care
What the data says
At $22M, Beam Therapeutics Inc.'s depreciation & amortization ranks #126 of 168 in the Health Care sector. Depreciation & Amortization has increased for 5 consecutive years, from $4M in FY2020 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +44.8%.
Increased from $20M to $22M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +44.8%
- 10-Year CAGR
- -
Sector benchmark
#126 of 168 in Health CareTop 74% of 168This company $22.3M Sector average $212.9M
▼
-89.5% below sector average
Key checks
Key Insights
- Beam Therapeutics Inc.'s depreciation & amortization has grown for 5 consecutive years.
- 5-year CAGR of +44.8%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 1.7% year-over-year.
- Ranks #43 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.3M | +1.7% |
| FY2024 | $21.9M | +9.6% |
| FY2023 | $20.0M | +41.5% |
| FY2022 | $14.1M | +89.9% |
| FY2021 | $7.5M | +112.7% |
| FY2020 | $3.5M | +0.0% |
| FY2019 | $3.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026